Catheter device and heart failure treatment instrument
The catheter device enhances the function of the lymphatic system, solves the problem of fluid retention in heart failure treatment, achieves more efficient tissue gap fluid transfer, improves the effect of heart failure treatment, and reduces the risk of recurrence in patients.
Patent Information
- Application Number
- PCT/CN2024/101383
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-06-27
- Filing Date
- 2024-06-25
- Publication Date
- 2025-01-02
AI Technical Summary
Among the existing treatment methods for heart failure, especially intravenous diuretics, the effect is poor, resulting in the incomplete relief of fluid retention, increasing the risk of recurrence and death in patients, and lacking treatment tools to improve the function of the lymphatic system.
A catheter device is designed to enhance the absorption and discharge function of the lymphatic system through a multi-cavity tube and balloon structure, promote the transfer of tissue gap fluid, and combine the axial flow pump and return tube to achieve Effective delivery of lymph fluid to avoid the risk of blood vessel blockage.
It effectively relieves fluid retention, improves the treatment effect of heart failure, reduces the risk of recurrence in patients, improves the function of the lymphatic system, promotes the transfer of tissue interstitial fluid, and enhances the effect of heart failure treatment.
Smart Images

Figure CN2024101383_02012025_PF_FP_ABST
Abstract
Description
Catheter devices and heart failure treatment devices
[0001] Cross-references
[0002] This disclosure refers to Chinese patent application No. 202310768924.5, entitled “Catheter device and heart failure treatment device”, filed on June 27, 2023, which is incorporated into this disclosure in its entirety by reference. Technical Field
[0003] The present disclosure relates to the technical field of medical equipment, and in particular to a catheter device and a heart failure treatment instrument. Background Art
[0004] Heart failure refers to a series of symptoms caused by insufficient blood perfusion due to dysfunction of the heart and inability to completely drain blood from the heart. Heart failure is generally divided into acute heart failure and chronic heart failure.
[0005] Acute heart failure is the most common type of acute left ventricular failure, which refers to a clinical syndrome characterized by acute myocardial damage or increased cardiac load, resulting in a sudden drop in cardiac output, increased pulmonary circulation pressure, and increased peripheral circulation resistance, which in turn causes pulmonary circulation congestion and acute pulmonary congestion, pulmonary edema, and may be accompanied by insufficient perfusion of tissues and organs and cardiogenic shock.
[0006] Chronic heart failure is divided into right heart failure and left heart failure. In right heart failure, the right ventricle's ability to eject blood decreases, leaving more blood in the right heart, leading to increased right heart pressure and difficulty in blood flow. Because the blood flowing into the right heart is systemic, it causes systemic congestion. Because the lower limbs are located lower in the body, congestion is most severe in the lower limbs. When water enters the surrounding tissues from the blood vessels in the lower limbs, it causes lower limb edema. In left heart failure, because the blood flowing into the left heart is pulmonary, it causes increased left atrial pressure and pulmonary venous pressure, which in turn causes pulmonary congestion and pulmonary edema.
[0007] In related technologies, depending on the different conditions of acute heart failure, the initial treatment is oxygen inhalation, and diuretics and cardiotonic drugs are given intravenously; if the condition still does not improve, vasoactive drugs are used to dilate and constrict blood vessels; if the condition is serious, blood pressure continues to drop or even cardiogenic shock occurs, it is necessary to monitor hemodynamics and adopt emergency non-drug treatment methods.
[0008] Treatments available in the prior art have limitations. For example, some patients respond well to intravenous diuretics, while others do not. This is because when there is excess fluid in the body, most of the excess fluid is not actually contained within the blood vessels, but rather in the interstitial spaces surrounding cells, a tissue called the interstitium. To fully decongest, excess fluid in the interstitial space must first be moved into the blood vessels. In healthy individuals, this function is achieved through the lymphatic system, which actively drains fluid into the large veins above the heart. However, in patients with acute heart failure, the pressure within the large veins can be very high, slowing or even preventing the flow of lymph fluid into the veins, thereby hindering the decongestion process. Studies have found that incomplete diuresis (i.e., fluid retention) is a strong predictor of hospital readmission and mortality. As many as half of acute heart failure patients are not fully diureticized upon discharge, resulting in approximately 25% of patients being readmitted within one month and approximately half of patients being readmitted within six months.
[0009] How to improve the effect of heart failure treatment is a technical problem that needs to be solved urgently.
[0010] Summary of the Invention
[0011] The embodiments of the present disclosure provide a catheter device and a heart failure treatment device to improve the effect of heart failure treatment.
[0012] According to one aspect of the present disclosure, a catheter device is provided, comprising: a multi-lumen tube, having a first lumen, a second lumen, a third lumen, and a fourth lumen that are not connected to each other, and a tube wall of the multi-lumen tube having a first through hole, a second through hole, and a third through hole in sequence in a direction away from the distal end thereof, wherein the first lumen runs through the multi-lumen tube and is used for allowing a guide wire to pass through; the distal end of the second lumen is closed, and the second lumen is connected to the second through hole, and the second lumen is used to transport lymph or contrast fluid through the second through hole; the third lumen is The distal end is closed, and the third lumen extends to the proximal end of the multi-lumen tube, the third lumen is connected to the first through hole, and is used to transport a pressurized medium through the first through hole; the distal end of the fourth lumen is closed, and the fourth lumen extends to the proximal end of the multi-lumen tube, the fourth lumen is connected to the third through hole, and is used to transport a pressurized medium through the third through hole; a first balloon is sealedly connected to the outer wall of the multi-lumen tube and is connected to the third lumen through the first through hole; and a second balloon is sealedly connected to the outer wall of the multi-lumen tube and is connected to the fourth lumen through the third through hole.
[0013] In some embodiments, the multi-lumen tube also has a fifth lumen for draining blood that is not connected to the first lumen, the second lumen, the third lumen, and the fourth lumen, and the tube wall of the multi-lumen tube is also provided with a fourth through hole and a fifth through hole, wherein the fourth through hole, the first through hole, the second through hole, the third through hole, and the fifth through hole are arranged in sequence in a direction away from the distal end of the multi-lumen tube, the distal end and the proximal end of the fifth lumen are closed, and the fifth lumen is connected to the fourth through hole and the fifth through hole.
[0014] In some embodiments, the catheter device also includes: a connecting seat, connected to the proximal end of the multi-lumen tube and having a first connector connected to the first lumen, a second connector connected to the second lumen, a third connector connected to the third lumen, and a fourth connector connected to the fourth lumen.
[0015] In some embodiments, the proximal end of the second lumen is closed, and the catheter device further includes: an axial flow pump disposed in the second lumen; and a reflux tube connected to the second lumen, for transporting the lymph fluid in the second lumen to the vein under the action of the axial flow pump.
[0016] In some embodiments, the second lumen, the third lumen, the fourth lumen, and the fifth lumen are distributed around the circumference of the first lumen, and the third lumen and the fourth lumen are arranged opposite to each other.
[0017] In some embodiments, a sealing material is used to seal the distal end of the fifth lumen and the distal end of the multi-lumen tube, and a sealing material is used to seal the proximal end of the fifth lumen and the proximal end of the multi-lumen tube.
[0018] In some embodiments, the number of the first through hole and the number of the third through hole are both plural.
[0019] In some embodiments, the catheter device further comprises: a first imaging element disposed on the periphery of the multi-lumen tube and located in the first balloon; and a second imaging element disposed on the periphery of the multi-lumen tube and located in the second balloon.
[0020] In some embodiments, the distal end of the multi-lumen tube is tapered.
[0021] In some embodiments, the materials of the first balloon and the second balloon respectively include at least one of polyamide, polyurethane, medical latex, medical silicone, polyamide polyether block copolymer, and polyethylene.
[0022] According to another aspect of the present disclosure, a heart failure treatment device is provided, comprising the catheter device according to any one of the aforementioned embodiments.
[0023] According to one or more embodiments of the present disclosure, the use of the above-mentioned catheter device in the treatment of heart failure can enhance the absorption and drainage functions of the lymphatic system, thereby more efficiently transferring the accumulated interstitial fluid, effectively alleviating fluid retention, and improving the effect of heart failure treatment.
[0024] These and other aspects of the disclosure will be apparent from and elucidated with reference to the embodiments described hereinafter. BRIEF DESCRIPTION OF THE DRAWINGS
[0025] In order to more clearly illustrate the technical solutions of the embodiments of the present application, the following briefly introduces the drawings required for use in the embodiments of the present application. Obviously, the drawings described below are only some embodiments of the present application. For those skilled in the art, other drawings can be obtained based on the drawings without inventive work. In the following description of exemplary embodiments in conjunction with the drawings, more details, features and advantages of the present disclosure are disclosed. In the drawings:
[0026] FIG1 is a schematic structural diagram of a catheter device according to some embodiments of the present disclosure; and
[0027] FIG2 is a schematic structural diagram of a catheter device according to other embodiments of the present disclosure.
[0028] Description of reference numerals:
[0029] 100-catheter device;
[0030] 110-Multi-lumen tube;
[0031] 11-first lumen;
[0032] 12-Second lumen;
[0033] 13-third lumen;
[0034] 14- fourth lumen;
[0035] 15-fifth lumen;
[0036] 16-first through hole;
[0037] 17- second through hole;
[0038] 18- third through hole;
[0039] 19- fourth through hole;
[0040] 20-fifth through hole;
[0041] 120-first balloon;
[0042] 130-second balloon;
[0043] 140-connection seat;
[0044] 41-first connector;
[0045] 42-second connector;
[0046] 43-third connector;
[0047] 44-fourth connector;
[0048] 160-axial flow pump;
[0049] 170- reflux pipe;
[0050] 51- sealing material;
[0051] 21-first developing element;
[0052] 22-Second developing element. DETAILED DESCRIPTION
[0053] Hereinafter, only certain exemplary embodiments are briefly described. As will be appreciated by those skilled in the art, the described embodiments may be modified in various ways without departing from the spirit or scope of the present disclosure. Therefore, the drawings and description are to be considered as illustrative in nature and not restrictive.
[0054] The human body possesses a vast network of lymphatic vessels and lymph nodes. These vessels converge into the body's two largest lymphatic ducts: the left thoracic duct and the right right lymphatic duct. These ducts then empty into the left and right subclavian veins, respectively. The thoracic duct, the thickest and longest lymphatic vessel in the body, collects lymph from the left upper and lower body, accounting for approximately 75% of the total body's lymph volume. The right lymphatic duct collects lymph from the right upper body, accounting for approximately 25% of the total body's lymph volume.
[0055] The function of lymph is to absorb substances released from blood vessels from the interstitial spaces and re-inject them into the bloodstream through the lymphatic circulation. However, lymphatic flow is limited. In some cases, blood congestion in the vessels increases internal pressure, leading to a significant increase in the release of substances. In these cases, the lymphatic system is unable to absorb and transport these substances back into the bloodstream in a timely manner. Studies have shown that the normal drainage function of the lymphatic system is significantly suppressed in most patients with acute heart failure during their illness.
[0056] The inventors of the present disclosure understand that improving the lymphatic system's ability to absorb and transport interstitial fluids and substances can theoretically effectively delay the symptoms of acute heart failure, but there are currently no products with related functions used in actual treatment.
[0057] The embodiments of the present disclosure provide a catheter device and a heart failure treatment device, which help to improve the effect of heart failure treatment.
[0058] As shown in FIG. 1 , a catheter device 100 provided in some embodiments of the present disclosure includes a multi-lumen tube 110 , a first balloon 120 , and a second balloon 130 . The multilumen tube 110 has a first lumen 11, a second lumen 12, a third lumen 13, and a fourth lumen 14 that are not connected to each other, and the wall of the multilumen tube 110 is provided with a first through hole 16, a second through hole 17, and a third through hole 18 in sequence away from its distal end, wherein the first lumen 11 runs through the multilumen tube 110 and is used for a guide wire (not shown) (i.e., a long guide wire hereinafter) to pass through, the second lumen 12 is connected to the second through hole 17 and is used to transport lymph or contrast fluid through the second through hole 17, the third lumen 13 is connected to the first through hole 16 and extends to the proximal end of the multilumen tube 110 and is used to transport a pressurized medium through the first through hole 16, and the fourth lumen 14 is connected to the third through hole 18 and extends to the proximal end of the multilumen tube 110 and is used to transport a pressurized medium through the third through hole 18. The first balloon 120 is sealed and connected to the outer wall of the multilumen tube 110 and is connected to the third lumen 13 through the first through hole 16. The second balloon 130 is sealed to the outer wall of the multilumen tube 110 and communicates with the fourth lumen 14 via the third through hole 18. In this embodiment, the first lumen 11 runs through the multilumen tube 110, and the distal ends of the second lumen 12, the third lumen 13, and the fourth lumen 14 are all in a closed state.
[0059] The catheter device 100 of the present embodiment is used to deliver contrast fluid to or extract lymph fluid from a lymphatic vessel. In the present embodiment, the end of the catheter device 100 or a component thereof that is closer to the operator in the direction of extension is defined as the "proximal end." Similarly, the end of the catheter device 100 or a component thereof that is farther from the operator in the direction of extension is defined as the "distal end."
[0060] In some embodiments of the present disclosure, the operation process of inserting the above-mentioned catheter device 100 into the human body is as follows: use a puncture needle to perform puncture → insert a short guide wire into the puncture needle → pull out the puncture needle → insert the sheath with the short guide wire as a guide → pull out the short guide wire → insert a long guide wire with the sheath as a guide → insert the above-mentioned catheter device 100 provided in the embodiment of the present disclosure with the long guide wire as a guide (the long guide wire passes through the first lumen 11) and position it (with the help of external imaging detection equipment) → pull out the long guide wire.
[0061] After the catheter device 100 is placed into the human body and positioned, an external pressurized medium input device is first used to fill the first balloon 120 through the third lumen 13 and the second balloon 130 through the fourth lumen 14. This allows the first and second balloons 120, 130 to occlude the blood vessel segment containing the lymphatic ostium when inflated, thereby creating a negative pressure region near the lymphatic ostium. Subsequently, an external contrast fluid input device is used to sequentially pass the contrast fluid through the second lumen 12, the second through-hole 17, and the valve structure at the lymphatic ostium into the lymphatic vessels. Alternatively, a suction device is used to sequentially draw lymph fluid out under negative pressure through the valve structure at the lymphatic ostium, the second through-hole 17, and the second lumen 12. This shows that the catheter device 100 of this embodiment does not need to enter the lymphatic vessels during intervention.
[0062] The use of the catheter device 100 of the embodiment of the present disclosure in the treatment of heart failure can enhance the absorption and drainage functions of the lymphatic system, thereby more efficiently transferring the accumulated interstitial fluid, effectively alleviating fluid retention, and improving the effect of heart failure treatment.
[0063] As shown in FIG. 1 , the distal end of the multi-lumen tube 110 may be designed to be tapered, so as to facilitate its smooth movement in the blood vessel.
[0064] In some embodiments of the present disclosure, as shown in Figure 1, the catheter device 100 also includes: a first developing element 21 provided on the periphery of the multi-lumen tube 110 and located in the first balloon 120, and a second developing element 22 provided on the periphery of the multi-lumen tube 110 and located in the second balloon 130.
[0065] The first and second imaging elements 21, 22 can be annular imaging elements attached to the outer wall of the multi-lumen tube 110. During surgery, external imaging detection equipment (such as X-ray detection equipment) can be used to detect the first and second imaging elements 21, 22, thereby accurately determining their positions, achieving precise occlusion of the blood vessel segment and accurate positioning of the lymphatic vessel orifice. The first and second imaging elements 21, 22 can be made of one or more materials selected from gold, platinum, iridium, tantalum, tungsten, and the like.
[0066] As shown in Figure 1, in some embodiments of the present disclosure, the multi-lumen tube 110 also has a fifth lumen 15 that is not connected to the first lumen 11, the second lumen 12, the third lumen 13 and the fourth lumen 14, and the tube wall of the multi-lumen tube 110 is also provided with a fourth through hole 19 and a fifth through hole 20, wherein the fourth through hole 19, the first through hole 16, the second through hole 17, the third through hole 18 and the fifth through hole 20 are arranged in sequence along the direction away from the distal end of the multi-lumen tube 110, the distal and proximal ends of the fifth lumen 15 are closed, and the fifth lumen 15 is connected to the fourth through hole 19 and the fifth through hole 20 for draining blood through the fourth through hole 19 and the fifth through hole 20.
[0067] In this embodiment, even if the first balloon 120 and the second balloon 130 block the blood vessel segment containing the lymphatic vessel opening in the filled state, blood can still be drained through the fourth through hole 19, the fifth lumen 15 and the fifth through hole 20, thereby achieving smooth flow. In this way, the surgical risks caused by blood vessel blockage can be greatly reduced or even avoided.
[0068] As shown in FIG1 , in some embodiments of the present disclosure, the catheter device 100 further includes a connector 140, which is connected to the proximal end of the multi-lumen tube 110 and has a first connector 41 communicating with the first lumen 11, a second connector 42 communicating with the second lumen 12, a third connector 43 communicating with the third lumen 13, and a fourth connector 44 communicating with the fourth lumen 14. The first connector 41 is used for inserting a guidewire, the second connector 42 is used for delivering lymphatic fluid or contrast fluid, and the third connector 43 and the fourth connector 44 are used for delivering pressurized media. Some of the above connectors can be Luer connectors, allowing multiple compatible fluids to be managed using the same tubing.
[0069] In the embodiment shown in FIG. 1 , lymph flows out of the catheter device 100 from the second connector 42 and can then pass through other catheters through extracorporeal circulation and re-enter the human body's venous vessels, thereby returning to the human circulation.
[0070] As shown in FIG2 , according to some embodiments of the present disclosure, a catheter device 100 has its second lumen 12 sealed at both the distal and proximal ends. The catheter device 100 also includes an axial flow pump 160 disposed within the second lumen 12, and a return tube 170 communicating with the second lumen 12. Return tube 170 is configured to transport lymph fluid within the second lumen 12 to a venous vessel under the action of the axial flow pump 160. This embodiment utilizes the negative pressure generated within the second lumen 12 by the axial flow pump 160 to draw lymph fluid into the second lumen 12. The lymph fluid is then delivered to the venous vessel via the return tube 170 and the intracorporeal circulation. Because the lymph fluid does not circulate extracorporeally, this effectively reduces surgical risks.
[0071] As shown in Figure 1, in some embodiments of the present disclosure, the second lumen 12, third lumen 13, fourth lumen 14, and fifth lumen 15 are arranged around the periphery of the first lumen 11, with the third lumen 13 and fourth lumen 14 arranged opposite each other. The cross-sectional shape of the first lumen 11 can be circular, and the second lumen 12, third lumen 13, fourth lumen 14, and fifth lumen 15 can have the same cross-sectional shape. This arrangement of the lumens in this embodiment allows for balanced pressure, which helps improve delivery efficiency and extend service life.
[0072] In some embodiments, the proximal end of the fifth lumen 15 is sealed with a sealing material 51 against the proximal end of the multi-lumen tube 110, and the distal end of the fifth lumen 15 is sealed with a sealing material 51 against the distal end of the multi-lumen tube 110, thereby forming a fifth lumen 15 with both ends closed. That is, when manufacturing the multi-lumen tube 110, a conventional extrusion process is first used to form the five-lumen tube body, and then the sealing material 51 is filled in to form the fifth lumen 15, making the manufacturing process of the multi-lumen tube 110 relatively simple. Similarly, the distal ends of the second lumen 12, the third lumen 13, and the fourth lumen 14 can also be sealed with a sealing material.
[0073] In the embodiment of the present disclosure, the number of the first through hole 16 and the number of the third through hole 18 are both plural, so that the efficiency of inflating the first balloon 120 and the second balloon 130 can be improved, so that they can expand quickly.
[0074] In the disclosed embodiment, first balloon 120 and second balloon 130 are made of a compliant material, enabling a larger expanded diameter at relatively low pressures. Furthermore, as pressure increases, their expanded diameters significantly increase, effectively anchoring them after expansion and providing reliable support within the blood vessel. The materials of first balloon 120 and second balloon 130 can each include at least one of polyamide, polyurethane, medical latex, medical silicone, polyamide-polyether block copolymer, and polyethylene.
[0075] The present disclosure also provides a heart failure treatment device, comprising the catheter device 100 of any of the aforementioned embodiments. In addition to the catheter device 100, the heart failure treatment device may also be equipped with a contrast fluid input device, a lymphatic fluid suction device, a pressurized medium input device, an X-ray detection device, and the like.
[0076] Based on the above-mentioned design of the catheter device 100, a heart failure treatment device can be used to achieve a better heart failure treatment effect.
[0077] It should be understood that in this specification, the terms "center", "longitudinal", "lateral", "length", "width", "thickness", "up", "down", "front", "back", "left", "right", "vertical", "horizontal", "top", "bottom", "inside", "outside", "clockwise", "counterclockwise", "axial", "radial", "circumferential" and the like indicate orientations or positional relationships or dimensions based on the orientations or positional relationships or dimensions shown in the accompanying drawings, and these terms are used only for the convenience of description, and do not indicate or imply that the device or element referred to must have a specific orientation, be constructed and operated in a specific orientation, and therefore cannot be understood as limiting the scope of protection of the present disclosure.
[0078] Furthermore, the terms "first," "second," "third," etc., are used for descriptive purposes only and should not be construed as indicating or implying relative importance or implicitly specifying the number of the technical features being referred to. Thus, a feature identified as "first," "second," or "third" may explicitly or implicitly include one or more of the features. Throughout the present disclosure, "plurality" means two or more, unless otherwise specifically defined.
[0079] In this disclosure, unless otherwise expressly specified or limited, terms such as "mounted," "connected," "connect," and "fixed" should be understood broadly. For example, they may refer to fixed connections, detachable connections, or integration; mechanical connections, electrical connections, or communication; direct connections or indirect connections through an intermediate medium; and internal connections between two components or interactions between two components. Those skilled in the art will understand the specific meanings of these terms in this disclosure based on specific circumstances.
[0080] In the present disclosure, unless otherwise expressly specified or limited, a first feature being "above" or "below" a second feature may include the first and second features being in direct contact, or may include the first and second features being in contact not directly but through another feature between them. Moreover, a first feature being "above," "above," and "above" a second feature includes the first feature being directly above and obliquely above the second feature, or simply indicates that the first feature is higher in level than the second feature. A first feature being "below," "below," and "below" a second feature includes the first feature being directly below and obliquely below the second feature, or simply indicates that the first feature is lower in level than the second feature.
[0081] This specification provides many different embodiments or examples that can be used to implement the present disclosure. It should be understood that these different embodiments or examples are purely exemplary and are not intended to limit the scope of protection of the present disclosure in any way. Those skilled in the art can conceive of various changes or replacements based on the disclosure of the specification of the present disclosure, all of which should be included within the scope of protection of the present disclosure. Therefore, the scope of protection of the present disclosure should be based on the scope of protection defined by the appended claims.
Claims
1. A catheter device, comprising: A multi-lumen tube has a first lumen, a second lumen, a third lumen and a fourth lumen which are not connected to each other, and a first through hole, a second through hole and a third through hole are sequentially provided on the tube wall of the multi-lumen tube in a direction away from the distal end thereof, wherein: The first lumen runs through the multi-lumen tube and is used for the guide wire to penetrate; The distal end of the second lumen is closed, and the second lumen is in communication with the second through hole, and the second lumen is used to transport lymph fluid or contrast fluid through the second through hole; The distal end of the third lumen is closed, and the third lumen extends to the proximal end of the multi-lumen tube, and the third lumen is communicated with the first through hole for conveying a pressurized medium through the first through hole; The distal end of the fourth lumen is closed, and the fourth lumen extends to the proximal end of the multi-lumen tube, and the fourth lumen is communicated with the third through hole for conveying a pressurized medium through the third through hole; a first balloon, sealedly connected to the outer wall of the multi-lumen tube and communicating with the third lumen through the first through hole; and The second balloon is sealed and connected to the outer wall of the multi-lumen tube and is in communication with the fourth lumen through the third through hole.
2. The catheter device according to claim 1, wherein The multi-lumen tube also has a fifth lumen for draining blood that is not connected to the first lumen, the second lumen, the third lumen and the fourth lumen, and the tube wall of the multi-lumen tube is also provided with a fourth through hole and a fifth through hole, wherein the fourth through hole, the first through hole, the second through hole, the third through hole and the fifth through hole are arranged in sequence along a direction away from the distal end of the multi-lumen tube, the distal end and the proximal end of the fifth lumen are closed and the fifth lumen is connected to the fourth through hole and the fifth through hole.
3. The catheter device of claim 2, further comprising: A connecting seat is connected to the proximal end of the multi-lumen tube and has a first connector connected to the first lumen, a second connector connected to the second lumen, a third connector connected to the third lumen, and a fourth connector connected to the fourth lumen.
4. The catheter device according to claim 2 or 3, wherein: The proximal end of the second lumen is closed, and the catheter device further comprises: an axial flow pump, disposed in the second lumen; and A reflux tube is communicated with the second lumen and is used to transport the lymph fluid in the second lumen to the vein under the action of the axial flow pump.
5. The catheter device according to any one of claims 2 to 4, wherein: The second tube cavity, the third tube cavity, the fourth tube cavity and the fifth tube cavity are distributed around the circumference of the first tube cavity, and the third tube cavity and the fourth tube cavity are arranged opposite to each other.
6. The catheter device according to any one of claims 2 to 5, wherein: The distal end of the fifth lumen is blocked with the distal end of the multi-lumen tube by a blocking material, and the proximal end of the fifth lumen is blocked with the proximal end of the multi-lumen tube by a blocking material.
7. The catheter device according to any one of claims 1 to 6, wherein: The number of the first through holes and the number of the third through holes are respectively plural.
8. The catheter device according to any one of claims 1 to 7, further comprising: A first developing element, disposed on the outer periphery of the multi-lumen tube and located in the first balloon; as well as The second developing element is arranged on the outer periphery of the multi-lumen tube and is located in the second balloon.
9. The catheter device according to any one of claims 1 to 8, wherein: The distal end of the multi-lumen tube is tapered.
10. The catheter device according to any one of claims 1 to 9, wherein: The materials of the first balloon and the second balloon include at least one of polyamide, polyurethane, medical latex, medical silicone, polyamide polyether block copolymer, and polyethylene.
11. A heart failure treatment device, comprising: A catheter device according to any one of claims 1 to 10.
Citation Information
Patent Citations
Catheter and method for isolating region in hollow organ of mammal, and system based on such catheter, and use of such catheter
CN115243623A
Balloon sheathing canal and heart failure treatment instrument
CN116688326A
Catheter device and heart failure treatment instrument
CN116688327A
Catheter device and heart failure treatment instrument
CN116747413A
Multi-cavity thorax therapy tube
CN203469099U
